Network of Rare Blood Disorder Organizations (NRBDO) www.nrbdo.ca
Representatives of the Alberta Porphyria Society have been included in the NRBDO since 2010 even though porphyria is not a rare blood disorder. The members of this coalition support one another in their quest to provide better health care for the members of their organizations.
The Network of Rare Blood Disorder Organizations is a coalition of national patient groups, formed to share the best practices in health care delivery for people with rare blood disorders such as hereditary angioedema; aplastic anemia, Fanconi anemia, paroxysmal nocturnal hemoglobinuria (PNH), and myelodysplasia; primary immune deficiency; porphyria, sickle cell disease, thalassemia, thrombotic thrombocytopenic purpura (TTP), hemophilia and von Willebrand disease. They work, advocate and lobby together in a coordinated fashion on key issues to secure and maintain patient access to comprehensive care while empowering patients who have rare blood disorders. The goals of the network are to ensure that finite health care dollars are spent rationally so as to promote the health of our citizens, reduce pain and suffering, and help people to live as nearly normal lives as possible and to raise the level of awareness and knowledge of the patient groups’ roles in the following key issues:
2009: Progress in Comprehensive Care for Rare Blood Disorders Conference -- Presented by CSL Bering
2011: NRBDO - Alberta: Awareness and Education Day -- held in Edmonton, Alberta
CONTACT INFORMATION:
Network of Rare Blood Disorder Organizations
C/O Canadian Hemophilia Society
National office in Montreal
400-1255 University Street
Montreal, QC H3B 3B6
Tel.: 514-848-0503
Toll-free: 1-800-668-2686
Fax: 514-848-9661
E-mail: [email protected]
Website: www.nrbdo.ca
- Importance of patient registries to facilitate access to quality care and existing and emerging therapies
- Advantages of specialized care centers for complex rare disorders
- Improved access to drug therapies
- Tracking of blood and blood products to permit inventory management and effective recall and notification procedures
- Need for active adverse reaction reporting and post-marketing surveillance of therapies used to treat these disorders
- Treatment guidelines
- Educational guidelines to maintain same level of education across Canada
- Orphan drug legislation
- Conferences:
2009: Progress in Comprehensive Care for Rare Blood Disorders Conference -- Presented by CSL Bering
2011: NRBDO - Alberta: Awareness and Education Day -- held in Edmonton, Alberta
CONTACT INFORMATION:
Network of Rare Blood Disorder Organizations
C/O Canadian Hemophilia Society
National office in Montreal
400-1255 University Street
Montreal, QC H3B 3B6
Tel.: 514-848-0503
Toll-free: 1-800-668-2686
Fax: 514-848-9661
E-mail: [email protected]
Website: www.nrbdo.ca